The reiteration of an Outperform rating by Oppenheimer analyst Colin Rusch indicates a positive outlook for Microvast Holdings. The maintained price target of $8 also suggests that the analyst believes the stock is undervalued at current levels. This could potentially lead to an increase in the stock's price in the short term.